Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

People with alopecia areata have higher insulin resistance.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Frontal Fibrosing Alopecia might be an autoimmune disease.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.